Acrivon Therapeutics, Inc. (ACRV) Total Assets by Year
Acrivon Therapeutics, Inc. closed fiscal year 2025 with $129.7M in total assets, $17.2M in total liabilities and $112.5M in shareholder equity. This represents a decrease of 34.0% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Acrivon Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ACRV Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ACRV Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $99.1M-37.5% | $107.8M-38.9% | $129.7M-34.0% | $145.3M-32.3% | $158.6M-31.2% | $176.3M+46.3% | $196.6M+42.2% | $214.7M+42.1% | $230.6M+44.1% | $120.5M-29.2% | $138.3M-23.7% | $151.1M+72.3% |
| Total Liabilities | $12.4M-20.1% | $12.3M-22.8% | $17.2M-13.1% | $16.7M-6.2% | $15.5M+7.0% | $16.0M+27.2% | $19.8M+16.0% | $17.8M+37.5% | $14.5M+33.7% | $12.5M+28.9% | $17.1M+58.8% | $12.9M-90.3% |
| Total Equity | $86.7M-39.4% | $95.5M-40.4% | $112.5M-36.4% | $128.6M-34.7% | $143.0M-33.8% | $160.4M+48.5% | $176.8M+45.9% | $196.9M+42.5% | $216.1M+44.8% | $108.0M-32.7% | $121.2M-28.9% | $138.1M+402.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Acrivon Therapeutics, Inc. financials
Frequently Asked Questions
What was Acrivon Therapeutics, Inc.'s total assets in fiscal year 2025?
Acrivon Therapeutics, Inc. closed fiscal year 2025 with $129.7M in total assets, $17.2M in total liabilities and $112.5M in shareholder equity.
How fast is Acrivon Therapeutics, Inc.'s total assets growing?
Acrivon Therapeutics, Inc. (ACRV) total assets fell by 34.0% year over year, from $196.6M to $129.7M in fiscal year 2025.
How has Acrivon Therapeutics, Inc.'s total assets changed over the years?
Across the 5 fiscal years this page covers, Acrivon Therapeutics, Inc. (ACRV) total assets went from $106.6M in fiscal year 2021 to $129.7M in fiscal year 2025.
What was Acrivon Therapeutics, Inc.'s total assets in the most recent quarter?
Acrivon Therapeutics, Inc. (ACRV) reported $99.1M in total assets in Q2 2026. This represents a decrease of 37.5% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Acrivon Therapeutics, Inc. (ACRV) reported on that line in every period on record.